U S PHYSICAL THERAPY INC /NV Investment Income, Interest
U S PHYSICAL THERAPY INC /NV (USPH) reported Investment Income, Interest of $29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV investment income, interest for the quarter ending 2026-06-30 was $29.00K, a 3.57% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV investment income, interest for the quarter ending 2026-03-31 was $16.00K, a 33.33% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV investment income, interest for the quarter ending 2025-12-31 was $20.00K, a 93.46% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV investment income, interest for the quarter ending 2025-09-30 was $33.00K, a 96.76% decline year-over-year.
- U S PHYSICAL THERAPY INC /NV investment income, interest for fiscal 2025 was $105.00K, a 97.34% decline from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV investment income, interest for fiscal 2024 was $3.94M, a 4.43% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV investment income, interest for fiscal 2023 was $3.77M.
- U S PHYSICAL THERAPY INC /NV investment income, interest for fiscal 2022 was $0.00.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-07 | $45.00K 10-Q · filed 2026-08-07 | $65.00K derived: sum of 3 quarters · filed 2026-08-07 | $98.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $16.00K 10-Q · filed 2026-05-08 | $36.00K derived: sum of 2 quarters · filed 2026-05-08 | $69.00K derived: sum of 3 quarters · filed 2026-05-08 | $97.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $53.00K derived: sum of 2 quarters · filed 2026-02-27 | $81.00K derived: sum of 3 quarters · filed 2026-08-07 | $105.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $33.00K 10-Q · filed 2025-11-07 | $61.00K derived: sum of 2 quarters · filed 2026-08-07 | $85.00K 10-Q · filed 2025-11-07 | $391.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $28.00K 10-Q · filed 2026-08-07 | $52.00K 10-Q · filed 2026-08-07 | $358.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.38M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $24.00K 10-Q · filed 2026-05-08 | $330.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.35M derived: sum of 3 quarters · filed 2026-05-08 | $2.42M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $306.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.32M derived: sum of 2 quarters · filed 2026-02-27 | $2.40M derived: sum of 3 quarters · filed 2026-02-27 | $3.94M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.02M 10-Q · filed 2025-11-07 | $2.09M derived: sum of 2 quarters · filed 2025-11-07 | $3.63M 10-Q · filed 2025-11-07 | $5.22M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.07M 10-Q · filed 2025-08-08 | $2.62M 10-Q · filed 2025-08-08 | $4.20M derived: sum of 3 quarters · filed 2026-02-27 | $5.87M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $1.54M 10-Q · filed 2025-05-09 | $3.13M derived: sum of 2 quarters · filed 2026-02-27 | $4.80M derived: sum of 3 quarters · filed 2026-02-27 | $5.32M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.26M derived: sum of 2 quarters · filed 2026-02-27 | $3.77M derived: sum of 3 quarters · filed 2026-02-27 | $3.77M 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.67M 10-Q · filed 2024-11-08 | $2.19M derived: sum of 2 quarters · filed 2024-11-08 | $2.19M 10-Q · filed 2024-11-08 | $2.25M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $517.00K 10-Q · filed 2024-08-14 | $517.00K 10-Q · filed 2024-08-14 | $581.00K derived: sum of 3 quarters · filed 2025-03-03 | $581.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $64.00K 10-Q · filed 2024-05-08 | $64.00K derived: sum of 2 quarters · filed 2025-03-03 | $64.00K derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 derived: sum of 2 quarters · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |